Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 8/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | UTS2R | Q9UKP6 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL5777437 | 0.91 | ACKR3 (0.41) | MAPTHDAC1HDAC4HDAC6SMN1; SMN2 | |
| Trifluoroacetic Acid SCHEMBL5772750 | 0.87 | MAPT (0.40) | MAPTTRPV1SMN1; SMN2HPGDTSHR | |
| Trifluoroacetic Acid SCHEMBL5771103 | 0.86 | HDAC4 (0.36) | MAPTHDAC1HDAC4TRPV1TP53 | |
| Trifluoroacetic Acid SCHEMBL5774050 | 0.86 | TRPV1 (0.43) | MAPTHDAC1HDAC6TRPV1TP53 | |
| Trifluoroacetic Acid SCHEMBL5775717 | 0.85 | GSK3B (0.44) | TRPV1TP53SMN1; SMN2FFAR1 | |
| Trifluoroacetic Acid SCHEMBL5775554 | 0.85 | HDAC4 (0.43) | MAPTHDAC1HDAC4HDAC6TRPV1 | |
| Trifluoroacetic Acid SCHEMBL5776374 | 0.83 | MAPT (0.53) | MAPTTP53SMN1; SMN2HPGDTSHR | |
| Trifluoroacetic Acid SCHEMBL5772978 | 0.82 | GSK3B (0.52) | MAPTHDAC1HDAC6TRPV1SMN1; SMN2 | |
| Trifluoroacetic Acid SCHEMBL5773866 | 0.81 | ALDH1A1 (0.48) | MAPTTP53SMN1; SMN2 | |
| Trifluoroacetic Acid SCHEMBL5775794 | 0.81 | KCNH2 (0.38) | MAPTSMN1; SMN2HPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060084690-A1 | Isoxazole derivatives | MOMOSE YU | 2006-04-20 | — | — | US | disclosed |
| US-7022725-B2 | Isoxazole derivatives | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-04-04 | — | — | US | disclosed |
| US-20040048908-A1 | Isoxazole derivatives | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-03-11 | — | — | US | disclosed |
| EP-1340749-A1 | ISOXAZOLE DERIVATIVES | Takeda Chemical Industries, Ltd. (JP) | 2003-09-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060084690-A1 | Isoxazole derivatives | INSR, GPR119, INSRR | MAPT 4701/4885HDAC1 353/4885HDAC4 434/4885 |
| US-20040048908-A1 | Isoxazole derivatives | GPR119, INSR, IRS1 | MAPT 4763/4885HDAC1 184/4885HDAC4 497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.